GlassScriptPhysician profile
Summer Raquel Ross
NPI 1861665440
$1,805.65
in general payments reported to CMS, 2019-2025
17 companies · $461 in 2025
The $461 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $106 · 2021: $280 · 2022: $141 · 2023: $310 · 2024: $367 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $474.92 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $417.50 | 2022-2025 | Azstarys |
| Neos Therapeutics, LP | $136.66 | 2019-2024 | Cotempla Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $134.91 | 2019-2021 | |
| Sanofi Pasteur INC. | $117.90 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $77.90 | 2021-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Ironshore Pharmaceuticals INC. | $76.99 | 2022-2024 | |
| Tris Pharma INC | $58.91 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $56.78 | 2025 | Jornay Pm |
| Pfizer INC. | $52.90 | 2020-2024 | |
| Adlon Therapeutics L.P. | $47.17 | 2021 | |
| Novo Nordisk INC | $38.40 | 2023-2024 | Wegovy |
| Genzyme Corporation | $32.12 | 2022 | |
| Chiesi USA, INC. | $27.18 | 2025 | Filsuvez |
| Krystal Biotech INC | $22.86 | 2023 | Vyjuvek |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $18.11 | 2023 | Ycanth |
| Journey Medical Corporation | $14.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summer Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.